Literature DB >> 30397897

Effect of endometrial mechanical stimulation in an unselected population undergoing in vitro fertilization: futility analysis of a double-blind randomized controlled trial.

Ashley M Eskew1, Lauren D Reschke2, Candice Woolfolk2, Maureen B Schulte3, Christina E Boots4, Darcy E Broughton2, Patricia T Jimenez2, Kenan R Omurtag2, Sarah L Keller2, Valerie S Ratts2, Randall R Odem2, Emily S Jungheim2.   

Abstract

PURPOSE: Implantation failure is a major limiting factor of successful in vitro fertilization (IVF). The objective of this study was to determine if endometrial mechanical stimulation (EMS) by endometrial biopsy in the luteal phase of the cycle prior to embryo transfer (ET) improves clinical outcomes in an unselected subfertile population.
METHODS: Double-blind, randomized controlled trial of EMS versus sham biopsy and odds of clinical pregnancy after IVF and embryo transfer. Secondary outcomes included spontaneous miscarriage and live birth.
RESULTS: One hundred women enrolled and were randomized from 2013 to 2017. Enrollment was terminated after futility analysis showed no difference in clinical pregnancy between EMS versus control, 47.2% vs 61.7% (OR 0.55, 95% CI 0.25-1.23, p = 0.15). There were no significant differences between women who underwent EMS and those who did not in terms of positive pregnancy test 54.7% vs 63.8% (OR 0.69, 95% CI 0.31-1.53, p = 0.36), miscarriage 7.5% vs 2.1% (OR 3.76 95% CI 0.41-34.85, p = 0.22), or live birth 43.4% vs 61.7% (OR 0.48 95% CI 0.21-1.06, p = 0.07).
CONCLUSIONS: EMS in the luteal phase of the cycle preceding embryo transfer does not improve clinical outcomes in an unselected subfertile population and may result in a lower live birth rate. We caution the routine use of EMS in an unselected population.

Entities:  

Keywords:  Assisted reproductive technology; Embryo transfer; Endometrial injury; Endometrial mechanical stimulation; Endometrial scratch; In vitro fertilization

Mesh:

Year:  2018        PMID: 30397897      PMCID: PMC6420542          DOI: 10.1007/s10815-018-1356-5

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  6 in total

1.  Endometrial scratch to increase live birth rates in women undergoing first-time in vitro fertilisation: RCT and systematic review.

Authors:  Mostafa Metwally; Robin Chatters; Clare Pye; Munya Dimairo; David White; Stephen Walters; Judith Cohen; Tracey Young; Ying Cheong; Susan Laird; Lamiya Mohiyiddeen; Tim Chater; Kirsty Pemberton; Chris Turtle; Jamie Hall; Liz Taylor; Kate Brian; Anya Sizer; Helen Hunter
Journal:  Health Technol Assess       Date:  2022-01       Impact factor: 4.014

2.  The impact of endometrial injury on reproductive outcomes: results of an updated meta-analysis.

Authors:  Chen Nahshon; Lena Sagi-Dain; Martha Dirnfeld
Journal:  Reprod Med Biol       Date:  2020-09-17

3.  Endometrial scratch vs no intervention in egg donation cycles: the ENDOSCRATCH trial protocol.

Authors:  Alexandra Izquierdo; Laura de la Fuente; Katharina Spies; Jennifer Rayward; Lourdes López; David Lora; Alberto Galindo
Journal:  BMC Pregnancy Childbirth       Date:  2020-05-30       Impact factor: 3.007

4.  Impact of endometrial scratching on reproductive outcome in patients: A systematic review and meta-analysis.

Authors:  YiFan Kang; ZhiHong Wang; Yuan Yang; HuiZhi Liang; Xia Duan; QingZhuo Gao; ZhaoFang Yin
Journal:  Medicine (Baltimore)       Date:  2022-08-19       Impact factor: 1.817

5.  Endometrial injury in women undergoing in vitro fertilisation (IVF).

Authors:  Sarah F Lensen; Sarah Armstrong; Ahmed Gibreel; Carolina O Nastri; Nick Raine-Fenning; Wellington P Martins
Journal:  Cochrane Database Syst Rev       Date:  2021-06-10

Review 6.  Endometrial scratch in women undergoing first-time IVF treatment: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Mostafa Metwally; Robin Chatters; David White; Jamie Hall; Stephen Walters
Journal:  Reprod Biomed Online       Date:  2021-12-03       Impact factor: 4.567

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.